Earnings Outlook For Alnylam Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Alnylam Pharmaceuticals (NASDAQ:ALNY) is set to release its quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-1.36. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $151.8, down 28.87% over the last 52-week period.
November 01, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alnylam Pharmaceuticals is expected to report an EPS of $-1.36. The company's past earnings have had a mixed impact on the stock price. The stock is down 28.87% over the last year.
The company's earnings report is a key event that can significantly impact the stock price. Given the negative year-over-year performance and the estimated negative EPS, the short-term impact on the stock is likely to be negative.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100